Home > Drug Search >
  • Targets: Signal transducer and activator of transcription (STAT)
  •   > 
Drug Filter
Category:
chemistry (21) biology (6)
Status:
Approved (4) Withdrawn (1) BLA Filing (1) Phase Ⅲ (4) Phase Ⅱ (5) Phase Ⅰ (12)
Clinical Stage:
Pending (2) Active (9) Discontinued (11)
Bio-Type:
Recombinant enzyme (5) Fusion protein (1)
Company:
Dong Wha Pharmaceuticals (1) GlaxoSmithKline (5) Johnson & Johnson (1) Kissei (1) Lexicon Pharmaceutical (1) Novartis (2) Roche (1) Sanofi (3) Teijin Pharma (1) 3SBio (1) EnzymeRx (1) Selecta Biosciences (1) Virchow Group (1) Akros (1) Haikou Pharmaceutical (1) Apeptico (1) Mediolanum (1) Vrije Universiteit Brussel (1) Crealta Pharmaceutical (1) Sigma-Tau (1) Polaris (1) SciClone (1) Verta (1) Central South University (1) Dierepharma (1) Amgen (1) Array BioPharma (1) Astellas (1) AstraZeneca (1) Chiesi (1)
Indication:
Acute coronary syndrome (ACS) (1) Allergic rhinitis (AR) (1) Arthritis (1) Asthma (1) Chronic gout (1) Chronic obstructive pulmonary disease (COPD) (2) Coronary artery disease (CAD) (1) HCV infection (1) Tumour lysis syndrome (1) Hyperuricemia (2) Inflammatory bowel disease (1) Myelodysplastic syndrome (MDS) (1) Neuropathic pain (1) Psoriasis (2) Rheumatoid arthritis (RA) (7) Type 2 diabetes (4) Chronic gouty arthritis (1) Intermittent gouty arthritis (1) Acute Lung Injury (1) Type 1 diabetes (1) Plasma uric acid management (1) Adenosine deaminase deficiency (1) Chemotherapy-radiotherapy induced mucositis (1) Hepatic fibrosis (1) Gout (1) Organ fibrosis (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top